ReviewDiabetes, obesity & metabolism2019

Use of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations.

Chaicharn Deerochanawong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.